158 related articles for article (PubMed ID: 37956162)
1. The association between polypharmacy and health-related quality of life among non-dialysis chronic kidney disease patients.
Adjeroh L; Brothers T; Shawwa K; Ikram M; Al-Mamun MA
PLoS One; 2023; 18(11):e0293912. PubMed ID: 37956162
[TBL] [Abstract][Full Text] [Related]
2. Polypharmacy, chronic kidney disease, and incident fragility fracture: a prospective cohort study.
Wakasugi M; Yokoseki A; Wada M; Momotsu T; Sato K; Kawashima H; Nakamura K; Onodera O; Narita I
J Bone Miner Metab; 2022 Jan; 40(1):157-166. PubMed ID: 34729651
[TBL] [Abstract][Full Text] [Related]
3. Polypharmacy is a risk factor for mortality, severe chronic kidney disease, and liver disease among privately insured adults with cerebral palsy.
Whitney DG; Schmidt M; Haapala H
J Manag Care Spec Pharm; 2021 Jan; 27(1):51-63. PubMed ID: 33377441
[No Abstract] [Full Text] [Related]
4. Impact of Polypharmacy on Health-Related Quality of Life in Dialysis Patients.
Colombijn JMT; Bonenkamp AA; van Eck van der Sluijs A; Bijlsma JA; Boonstra AH; Özyilmaz A; Abrahams AC; van Jaarsveld BC;
Am J Nephrol; 2021; 52(9):735-744. PubMed ID: 34518456
[TBL] [Abstract][Full Text] [Related]
5. International prescribing patterns and polypharmacy in older people with advanced chronic kidney disease: results from the European Quality study.
Hayward S; Hole B; Denholm R; Duncan P; Morris JE; Fraser SDS; Payne RA; Roderick P; Chesnaye NC; Wanner C; Drechsler C; Postorino M; Porto G; Szymczak M; Evans M; Dekker FW; Jager KJ; Caskey FJ;
Nephrol Dial Transplant; 2021 Feb; 36(3):503-511. PubMed ID: 32543669
[TBL] [Abstract][Full Text] [Related]
6. Association between polypharmacy and health-related quality of life among cancer survivors in the United States.
Babcock ZR; Kogut SJ; Vyas A
J Cancer Surviv; 2020 Feb; 14(1):89-99. PubMed ID: 31792811
[TBL] [Abstract][Full Text] [Related]
7. Psychotropic polypharmacy and its association with health-related quality of life among cancer survivors in the USA: a population-level analysis.
Vyas A; Alghaith G; Hufstader-Gabriel M
Qual Life Res; 2020 Aug; 29(8):2029-2037. PubMed ID: 32207028
[TBL] [Abstract][Full Text] [Related]
8. Symptom burden and health-related quality of life in chronic kidney disease: A global systematic review and meta-analysis.
Fletcher BR; Damery S; Aiyegbusi OL; Anderson N; Calvert M; Cockwell P; Ferguson J; Horton M; Paap MCS; Sidey-Gibbons C; Slade A; Turner N; Kyte D
PLoS Med; 2022 Apr; 19(4):e1003954. PubMed ID: 35385471
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in end-stage renal disease patients: the effects of starting dialysis in the first year after the transition period.
Broers NJH; Martens RJH; Canaud B; Cornelis T; Dejagere T; Diederen NMP; Hermans MMH; Konings CJAM; Stifft F; Wirtz JJJM; Leunissen KML; van der Sande FM; Kooman JP
Int Urol Nephrol; 2018 Jun; 50(6):1131-1142. PubMed ID: 29582338
[TBL] [Abstract][Full Text] [Related]
10. Association among sleep, depression, and health-related quality of life in patients with non-dialysis chronic kidney disease during the coronavirus disease 2019 pandemic.
Chen Y; Li M; Zhou L; Chen C; Li N; Meng J; Wei G; Zhang H; Feng L; Li H; Sun J; Liu H
Ann Palliat Med; 2022 Jun; 11(6):1865-1875. PubMed ID: 35272471
[TBL] [Abstract][Full Text] [Related]
11. Perceived Health and Quality of Life in Patients With CKD, Including Those With Kidney Failure: Findings From National Surveys in France.
Legrand K; Speyer E; Stengel B; Frimat L; Ngueyon Sime W; Massy ZA; Fouque D; Laville M; Combe C; Jacquelinet C; Durand AC; Edet S; Gentile S; Briançon S; Ayav C
Am J Kidney Dis; 2020 Jun; 75(6):868-878. PubMed ID: 31879215
[TBL] [Abstract][Full Text] [Related]
12. Health related quality of life and healthcare utilization among adults with diabetes and kidney and eye complications in the United States.
Meraya AM; Alwhaibi M
Health Qual Life Outcomes; 2020 Mar; 18(1):85. PubMed ID: 32228619
[TBL] [Abstract][Full Text] [Related]
13. Association between polypharmacy and health-related quality of life among US adults with cardiometabolic risk factors.
Vyas A; Kang F; Barbour M
Qual Life Res; 2020 Apr; 29(4):977-986. PubMed ID: 31786690
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and associated factors among chronic kidney disease patients at Zewditu Memorial and Tikur Anbessa Specialised Hospitals, Ethiopia: a cross-sectional study design.
Berhe T; Tegegne GT; Berha AB
BMJ Open; 2023 Jun; 13(6):e069712. PubMed ID: 37263701
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Health-Related Quality of Life in Chronic Kidney Disease Patients: A Hospital-Based Cross-Sectional Study.
Sharma S; Kalra D; Rashid I; Mehta S; Maity MK; Wazir K; Gupta S; Ansari SA; Alruqi OS; Khan R; Khan I; Anwar S
Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893506
[No Abstract] [Full Text] [Related]
16. Cross-Sectional Observational Study on Association of Polypharmacy With Health-Related Quality of Life in Patients With Hypertension.
Paramba T; Zilate S
Cureus; 2022 Oct; 14(10):e30361. PubMed ID: 36407267
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life in different stages of chronic kidney disease and at initiation of dialysis treatment.
Pagels AA; Söderkvist BK; Medin C; Hylander B; Heiwe S
Health Qual Life Outcomes; 2012 Jun; 10():71. PubMed ID: 22710013
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life and associated outcomes among hemodialysis patients of different ethnicities in the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Lopes AA; Bragg-Gresham JL; Satayathum S; McCullough K; Pifer T; Goodkin DA; Mapes DL; Young EW; Wolfe RA; Held PJ; Port FK;
Am J Kidney Dis; 2003 Mar; 41(3):605-15. PubMed ID: 12612984
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of polypharmacy and associated adverse health outcomes in adult patients with chronic kidney disease: protocol for a systematic review and meta-analysis.
Okpechi IG; Tinwala MM; Muneer S; Zaidi D; Ye F; Hamonic LN; Khan M; Sultana N; Brimble S; Grill A; Klarenbach S; Lindeman C; Molnar A; Nitsch D; Ronksley P; Shojai S; Soos B; Tangri N; Thompson S; Tuot D; Drummond N; Mangin D; Bello AK
Syst Rev; 2021 Jul; 10(1):198. PubMed ID: 34218816
[TBL] [Abstract][Full Text] [Related]
20. Association of Polypharmacy with Kidney Disease Progression in Adults with CKD.
Kimura H; Tanaka K; Saito H; Iwasaki T; Oda A; Watanabe S; Kanno M; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
Clin J Am Soc Nephrol; 2021 Dec; 16(12):1797-1804. PubMed ID: 34782408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
